These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5684392)

  • 41. Tranquilizing effects of SKF 14336 in chronic schizophrenic patients.
    Freeman H; Oktem MR
    Curr Ther Res Clin Exp; 1966 Aug; 8(8):395-9. PubMed ID: 4958156
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of flupenthixol in the treatment and rehabilitation of chronic schizophrenia].
    Molcan J; Kukucová H; Koníková M
    Bratisl Lek Listy; 1971 Sep; 56(3):295-300. PubMed ID: 5114543
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical testing of a new long-term neuroleptic (Fluspirilene) with special reference to the neuroleptic threshold].
    Haase HJ; Frank T; Knaack M; Lehnhardt C; Richter-Peill H
    Nervenarzt; 1968 Jun; 39(6):275-9. PubMed ID: 5712433
    [No Abstract]   [Full Text] [Related]  

  • 44. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinico-neuroleptic studies of the neuroleptic agent Propericiazine with special consideration of the neuroleptic threshold].
    Haase HJ; Deinzer C; Rhinow E
    Med Welt; 1968 Jul; 27():1580-4. PubMed ID: 4388432
    [No Abstract]   [Full Text] [Related]  

  • 46. A review of treatment of 176 schizophrenic patients in the mental hospital Pabna.
    Rahman R
    Br J Psychiatry; 1968 Jun; 114(511):775-7. PubMed ID: 5665962
    [No Abstract]   [Full Text] [Related]  

  • 47. Preliminary method for study of LSD with children.
    Rolo A; Krinsky LW; Abramson H; Goldfarb L
    Int J Neuropsychiatry; 1965 Dec; 1(6):552-5. PubMed ID: 5886534
    [No Abstract]   [Full Text] [Related]  

  • 48. [Differential diagnostic considerations in the early detection of juvenile secondary schizophrenia].
    Seebandt G
    Prax Kinderpsychol Kinderpsychiatr; 1968; 17(2):47-50. PubMed ID: 5716674
    [No Abstract]   [Full Text] [Related]  

  • 49. Experience with fluspirilene (R 6218), a long-acting neuroleptic.
    van Epen JH
    Psychiatr Neurol Neurochir; 1970; 73(4):277-84. PubMed ID: 5478771
    [No Abstract]   [Full Text] [Related]  

  • 50. The place of thiothixene among the thioxanthenes.
    Sterlin C; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):205-14. PubMed ID: 4623599
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of neuroleptic chemotherapies on schizophrenic psychoses.
    Deniker P
    Am J Psychiatry; 1978 Aug; 135(8):923-7. PubMed ID: 665834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of molindone in disturbed preschool children.
    Campbell M; Fish B; Shapiro T; Floyd A
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):28-33. PubMed ID: 4992563
    [No Abstract]   [Full Text] [Related]  

  • 53. Thiothixene (P-4657B): a controlled evaluation in chronic schizophrenic patients.
    Gallant DM; Bishop MP; Timmons E; Gould AR
    Curr Ther Res Clin Exp; 1966 Apr; 8(4):153-8. PubMed ID: 4956320
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative study of thiothixene and trifluoperazine in schizophrencs in the acute phase].
    Hillel JM; Albert JM; Tetreault L
    Encephale; 1970; 59(2):162-79. PubMed ID: 5458711
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 56. [Schizophrenic syndromes improving without neuroleptic drug treatment (author's transl)].
    Vinar O; Taussigová D
    Cesk Psychiatr; 1976 Jun; 72(3):176-81. PubMed ID: 786481
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of schizophrenic states with a new long-acting tranquilizer].
    Buisson JF
    Ann Med Psychol (Paris); 1973 Feb; 2(2):287-93. PubMed ID: 4749248
    [No Abstract]   [Full Text] [Related]  

  • 59. [Report on the clinical test of the long-term neuroleptic agent penfluridol].
    Glatzel J
    Med Welt; 1973 Dec; 24(51):2044-6. PubMed ID: 4204355
    [No Abstract]   [Full Text] [Related]  

  • 60. [Possibilities and limits of depot neuroleptic therapy of schizophrenic psychoses].
    Glatzel J
    Ther Ggw; 1970 Jun; 109(6):834-6 passim. PubMed ID: 5453883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.